Cell Biotech Co. Ltd (049960) — Strategic Asset Allocation Index
Cell Biotech Co. Ltd (049960) has a Strategic Asset Allocation Index of 24.2% as of March 2025. Strategic assets (PP&E of ₩29.77 Billion plus long-term investments of ₩-) total ₩29.77 Billion, measured against net assets of ₩123.28 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 049960 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cell Biotech Co. Ltd Strategic Asset Allocation Index (2011–2024)
This chart shows how Cell Biotech Co. Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of March 2025, the index stands at 24.2%, representing strategic assets of ₩29.77 Billion against net assets of ₩123.28 Billion KRW. For live market cap and overall valuation, see market value of Cell Biotech Co. Ltd.
Annual Strategic Asset Allocation Index for Cell Biotech Co. Ltd (2011–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Cell Biotech Co. Ltd from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Cell Biotech Co. Ltd (049960) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 24.5% | ₩30.46 Billion | ₩30.46 Billion | ₩- | ₩124.17 Billion | ▼ -4.9 pp |
| 2023 | 29.4% | ₩32.94 Billion | ₩32.94 Billion | ₩- | ₩111.89 Billion | ▼ -1.7 pp |
| 2022 | 31.1% | ₩33.64 Billion | ₩33.64 Billion | ₩- | ₩108.09 Billion | ▼ -0.8 pp |
| 2021 | 31.9% | ₩34.06 Billion | ₩34.06 Billion | ₩- | ₩106.69 Billion | ▼ -4.7 pp |
| 2020 | 36.6% | ₩36.60 Billion | ₩36.60 Billion | ₩- | ₩99.98 Billion | ▲ +1.8 pp |
| 2019 | 34.8% | ₩36.07 Billion | ₩36.07 Billion | ₩- | ₩103.60 Billion | ▲ +7.7 pp |
| 2018 | 27.1% | ₩28.65 Billion | ₩28.65 Billion | ₩2.00 Million | ₩105.62 Billion | ▲ +1.1 pp |
| 2017 | 26.0% | ₩23.48 Billion | ₩23.18 Billion | ₩294.77 Million | ₩90.20 Billion | ▲ +2.5 pp |
| 2016 | 23.5% | ₩19.80 Billion | ₩19.52 Billion | ₩271.59 Million | ₩84.15 Billion | ▼ -4.9 pp |
| 2015 | 28.5% | ₩19.57 Billion | ₩18.78 Billion | ₩792.04 Million | ₩68.76 Billion | ▼ -5.5 pp |
| 2014 | 33.9% | ₩17.76 Billion | ₩16.77 Billion | ₩994.06 Million | ₩52.36 Billion | ▼ -6.3 pp |
| 2013 | 40.2% | ₩17.32 Billion | ₩16.46 Billion | ₩864.00 Million | ₩43.05 Billion | ▲ +6.5 pp |
| 2012 | 33.7% | ₩12.28 Billion | ₩10.94 Billion | ₩1.34 Billion | ₩36.42 Billion | ▲ +7.5 pp |
| 2011 | 26.3% | ₩8.34 Billion | ₩8.34 Billion | ₩- | ₩31.77 Billion | — |